research

On February 4th, BIO hosted a media briefing on how efforts to restrict gene patenting and licensing would threaten advances in public health and harm the national economy.

Participants included:

On February 4th, BIO hosted a media briefing on how efforts to restrict gene patenting and licensing would threaten advances in public health and harm the national economy. Participants included:

Patient advocacy groups have many different roles.  They are educators, they provide a support system for individuals and families of people living with illness, they lobby for increased research, and are increasingly providing funding to biotech companies to encourage further research and development of promising, and potentially life-saving therapies.  At the 2009 BIO International Convention, we met with patients  and patient advocates to learn more about how advocacy groups are working together with biotech researchers to promote innovative research and creation of therapies that may one d

Louisiana is one of just a few states that do not yet have a BIO affiliate. I was invited to speak to community leaders in New Orleans by Jim McNamara, a local real estate investor who is presently the Secretary of the Board of the New Orleans BioInnovation Center, a Member of the Greater New Orleans Biosciences Economic Development District and a Commissioner of the Downtown Development District of New Orleans.

Jim believes biotechnology can be key to the Big Easy’s recovery from the ravages of Hurricane Katrina.

Join Dr. Targan as he explains biotech therapies - what they are, why they are different from traditional therapies, and how you and I are benefitting from them daily.

Download to listen or view the podcast.

BIOtech Now interviews Corrine Young, director of government affairs for Myriant Technologies LLC.

Research on agriculture and food production is one of the foundations of modern society. According to one of my colleagues, it’s a proven fact that people who eat food live longer than people who do not.

Just about everyone knows that a balanced diet can lead to better health. In the United States, we take our food – and all those benefits – for granted. We expect that our food will be easily available, safe, and affordable.

But the food supply is not so secure in other parts of the world.

CureDuchenne is a non-profit organization founded in 2003 by Debra and Paul Miller, parents of a Duchenne boy. CureDuchenne’s vision is its name to cure Duchenne muscular dystrophy. CureDuchenne aggressively seeks the most promising, leading edge research breakthroughs and expedites them to the clinical trial process. The ultimate goal…give the boys that have Duchenne now a chance to live a normal life by expediting the cure and/or the availability of therapies that can give quality of life to Duchenne boys, much like insulin does for diabetics.

BIO is a strong advocate for federal funding of stem cell research and welcomes President Obama’s Executive Order which will allow federal funding of more embryonic stem cell research. We look forward to working with Congress and the Administration to develop public policies that enable our industry to turn the hope of basic research to the reality of cures and advanced therapies.

BIOtech Now interviews Dr. Richard A.